摘要
To the Editor:Liver fibrosis is a consequence of several chronic liver diseases(CLDs).Accurate assessment of fibrosis severity is important for the management of patients with CLDs.Liver biopsy is the reference standard to follow fibrosis progression,but it is limited by its invasiveness,sampling error,and the intra-and interobserver variability.Therefore,developing non-invasive methods is essential for liver fibrosis assessment.
基金
This work was supported by grants of the National Natural Science Foundation of China(No.81571675 and No.81873897).
